Prognostic analysis of patients suffering from intrahepatic cholangiocarcinoma

  • Zhong Chen
  • Jianjun Yan
  • Liang Huang
  • Yiqun Yan



The outcome of surgical treatment of patients with intrahepatic cholangiocarcinoma (ICC) is poor. This study was designed to analyze prognostic factors after surgical procedure for ICCs.


A retrospective clinical analysis was made in 183 cases of ICC, admitted to Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China, from December 1996 to July 2003. Fifteen clinicopathologic factors that could possibly influence survival were selected. A multivariate analysis of these individuals was performed using the Cox Proportional Hazards Model.


The accumulative 1-, 3- and 5-year survival rates of the patients were 51.3%, 21.6% and 11.8% respectively. The statistical analysis showed that surgical procedure, lymph node metastasis, serum level of CA19-9 and pathological differentiation grade affected postoperative survival significantly, but transfusion, postoperative radiotherapy and chemotherapy, diameter of tumor, serum level of AFP, cirrhosis, preoperative total serum bilirubin level (TBIL), ratio of albumin to globulin (A/G), sex and age were not significant factors influencing postoperative survival.


Major hepatectomy with systematic lymph node dissection may be recommended for the surgical treatment of ICC. Aggressive treatment and prevention on postoperative intrahepatic recurrence and lymph node metastasis are important strategy to improve the survival for ICC.

Key words

intrahepatic cholangiocarcinoma (ICC) surgical procedures, operative prognosis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology, 2001, 33: 1353–1357.PubMedCrossRefGoogle Scholar
  2. 2.
    Kawarada Y, Mizumoto R. Cholangiocellular carcinoma of the liver. Am J Surg, 1984, 147: 354–359.PubMedCrossRefGoogle Scholar
  3. 3.
    Kim HJ, Yun SS, Jung KH, et al. Intrahepatic cholangiocarcinoma in Korea. J Hepatobil Panc Surg, 1999, 6: 142–148.CrossRefGoogle Scholar
  4. 4.
    Shirabe K, Shimada M, Harimoto N, et al. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery, 2002, 131: 159–164.CrossRefGoogle Scholar
  5. 5.
    Hirohashi K, Uenishi T, Kubo S, et al. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology, 2002, 49: 326–329.PubMedGoogle Scholar
  6. 6.
    Chou FF, Sheen-Chen SM, Chen YS, et al. Surgical treatment of cholangiocarcinoma. Hepatogastroenterology, 1997, 44: 760–765.PubMedGoogle Scholar
  7. 7.
    Kawarada Y, Yamagiwa K, Das BC. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg, 2002, 183: 679–685.PubMedCrossRefGoogle Scholar
  8. 8.
    Ercolani G, Grazi GL, Ravaioli M, et al. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg, 2004, 239: 202–209.PubMedCrossRefGoogle Scholar
  9. 9.
    Yamamoto M, Takasaki K, Yoshikawa T. Extended resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobil Panc Surg, 1999, 6: 117–121.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Zhong Chen
    • 1
    • 2
  • Jianjun Yan
    • 2
  • Liang Huang
    • 2
  • Yiqun Yan
    • 2
  1. 1.Department of Hepatobiliary SurgeryJinan Military HospitalJinanChina
  2. 2.Department of Hepatic Surgery, Eastern Hepatobiliary Surgery HospitalSecond Military Medical UniversityShanghaiChina

Personalised recommendations